Nakajima Kenichi, Mita Tomoya, Osonoi Yusuke, Azuma Kosuke, Takasu Toshiyuki, Fujitani Yoshio, Watada Hirotaka
Department of Metabolism & Endocrinology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Department of Metabolism & Endocrinology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan ; Center for Molecular Diabetology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Int J Endocrinol. 2015;2015:406394. doi: 10.1155/2015/406394. Epub 2015 Aug 20.
Epidemiological data suggest that postprandial hyperglycaemia and hypoglycaemia are potential risk factors for cardiovascular disease. However, the effects of repetitive postprandial glucose spikes, repetitive hypoglycaemia, and their combination on the progression of atherosclerosis remain largely unknown. The present study investigated the effects of rapid rises and falls in glucose, and their combination, on the progression of atherosclerosis in apolipoprotein (apo) E-deficient mice. In this study, apo E-deficient mice with forced oral administration of glucose twice daily for 15 weeks were used as a model of repetitive postprandial glucose spikes, and apo E-deficient mice given an intraperitoneal injection of insulin once a week for 15 weeks were used as a model of repetitive hypoglycaemia. In addition, we established a model of both repetitive postprandial glucose spikes and hypoglycaemia by combining the above interventions. Atherosclerosis was evaluated in all mice by oil red O staining. Administration of ipragliflozin, a selective inhibitor of sodium-glucose cotransporter 2, in the mouse model of repetitive glucose spikes inhibited the progression of atherosclerosis, whereas long-term repetitive glucose spikes, repetitive hypoglycaemia, and their combination had no significant impact on atherosclerosis. However, repetitive hypoglycaemia was associated with poor survival rate. The results showed that repetitive hypoglycaemia reduces the survival rate without associated progression of atherosclerosis in apo E-deficient mice.
流行病学数据表明,餐后高血糖和低血糖是心血管疾病的潜在危险因素。然而,餐后反复出现的血糖峰值、反复出现的低血糖及其联合作用对动脉粥样硬化进展的影响在很大程度上仍不清楚。本研究调查了血糖的快速升降及其联合作用对载脂蛋白E(apo)缺乏小鼠动脉粥样硬化进展的影响。在本研究中,每天两次强制口服葡萄糖持续15周的apo E缺乏小鼠被用作反复餐后血糖峰值的模型,每周一次腹腔注射胰岛素持续15周的apo E缺乏小鼠被用作反复低血糖的模型。此外,我们通过结合上述干预措施建立了反复餐后血糖峰值和低血糖的联合模型。通过油红O染色对所有小鼠的动脉粥样硬化进行评估。在反复血糖峰值的小鼠模型中,给予钠-葡萄糖协同转运蛋白2的选择性抑制剂依帕列净可抑制动脉粥样硬化的进展,而长期反复出现的血糖峰值、反复出现的低血糖及其联合作用对动脉粥样硬化没有显著影响。然而,反复低血糖与低生存率相关。结果表明,反复低血糖会降低apo E缺乏小鼠的生存率,且与动脉粥样硬化进展无关。